Millipore and the University of Massachusetts Lowell Dedicate the Millipore Process Development Laboratory

Millipore and the University of Massachusetts Lowell Dedicate the Millipore Process Development Laboratory

Billerica, Massachusetts-April 9, 2009- Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced the opening of the Millipore Corporation Process Development Laboratory in partnership with the University of Massachusetts (UMass) Lowell.

Jean-Paul Mangeolle, President of Millipore's Bioprocess Division and University of Massachusetts Lowell's Chancellor Marty Meehan attended the dedication. A number of industry-leading organizations were also on hand to mark the event and to support the Massachusetts BioManufacturing Center at UMass Lowell.

"This UMass Lowell-Millipore partnership is the perfect example of the value both institutions bring to the regional economy," said Meehan. "Millipore's donation will allow us to train our students on state-of-the-art equipment they will use in their future-or current-jobs. Together, UMass Lowell and Millipore are helping to grow the life sciences workforce."

Millipore donated over $225,000 in equipment and services to the laboratory, which will be used for downstream purification research as well as training for students and industry professionals. The state-of-the-art equipment includes clarification, chromatography, ultrafiltration/diafiltration (UF/DF) systems, and disposable mixing systems.

"Millipore strives to be at the forefront of innovation," said Jean-Paul Mangeolle, President of Millipore's Bioprocess Division. "Given the dynamic nature of our industry, access to cutting-edge technology and solutions is critical. By partnering with higher education institutions such as UMass Lowell, we further our own knowledge while supporting the local community and helping to educate students who will one day enter the workforce."

The Millipore Corporation Process Development Laboratory is adjacent to, and works in tandem with, the recently outfitted IPS-Wyeth-Dakota Systems BioManufacturing Pilot Plant. Both are part of the Massachusetts BioManufacturing Center at UMass Lowell, an interdisciplinary research, development and education initiative supported by the University of Massachusetts and the Commonwealth. It assists biotechnology companies in developing procedures leading to industry compliant manufacturing processes. Through education, applied research and process development, the center offers solutions that improve productivity, quality and cost of biomanufacturing operations. The lab and the pilot plant position the Massachusetts BioManufacturing Center at UMass Lowell in the vanguard of biotech manufacturing instruction and allows it to offer a wider range of client services to area biotech firms.

About Millipore

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees in 30 countries worldwide. For more information, visit http://www.millipore.com.

About UMass Lowell

UMass Lowell, with a national reputation in science, engineering and technology, is committed to educating students for lifelong success in a diverse world and conducting research and outreach activities that sustain the economic, environmental and social health of the region. UML offers its 12,000 students more than 120 degree choices, internships, five-year combined bachelor's to master's programs and doctoral studies in the colleges of Arts and Sciences, Engineering and Management, the School of Health and Environment, and the Graduate School of Education. www.uml.edu

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.